Technology Opportunities

Refine / Revise Search2 technologies found
page 1 of 1
Short Inhibitory Peptide for Treatment of Rheumatoid Arthritis and Psoriatic Arthritis (Yissum)
Categories Peptide/Protein, Inflammation, Autoimmunity, Rheumatoid arthritis Development Stage Feasibility demonstrated in mouse models. Proven Long term stability Patent Status Provisional Patent application was submitted Market Prevalence of rheumatoid arthritis is ...
Scientific Contact: David Naor
More Details...
Therapeutic effect of RHAMM (CD168) on type 1 and type 2 diabetes as well as on other autoimmune diseases (Yissum)
Categories Peptide/Protein, Inflammation, Autoimmunity, Diabetes Development Stage Feasibility demonstrated in mouse models of both type 1 and type 2 diabetes (abbreviated T1D and T2D, respectively) Patent Status Provisional Patent application was submitted Market ...
Scientific Contact: David Naor
More Details...
ITTN's partners are affiliated with some of the world's leading Educational and Research Institutions.